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Abstract
Background Spontaneous reporting of adverse drug reac-
tions (ADRs) remains one of the most efficient methods to
detect new, unusual, and severe ADRs. Community phar-
macy professionals (CPPs) play a fundamental role in the
reporting of spontaneous ADRs. The aim of this study was
to describe the attitudes and knowledge of different CPP
groups regarding the spontaneous reporting of ADRs and to
identify the factors that can influence ADR under-
reporting.
Methods A cross-sectional descriptive study was con-
ducted in CPPs (156 pharmacists and 40 pharmacy tech-
nicians) working in 49 pharmacies in Coimbra, Portugal. A
survey of the knowledge and attitudes of CPPs towards
reporting ADRs and the factors that encourage and dis-
courage ADR reporting was constructed and personally
delivered to the pharmacies.
Results The response rate was 82.0%. The seriousness and
the unusualness of the reaction were the most important
motives to report ADRs (98.0 and 97.4% of respondents,
respectively). CPPs also considered ADR reporting to be a
professional obligation (96.4%), but ‘‘don’t feel the need to
report well-known ADRs’’ (54.1%). Other attitudes asso-
ciated with under-reporting were lack of time (50.0%),
method of reporting (38.3%), and fear of legal liability
(29.6%).
Conclusions CPPs’ knowledge and behavior play a sig-
nificant role in ADR reporting. Despite the differences in
their educational syllabus, there were no statistical differ-
ences between pharmacists and pharmacy technicians with
regard to their perception of the importance of ADR reports
or the factors that affect their reporting. It may be possible
to reduce the under-reporting of ADRs by introducing
educational interventions based on the attitudes related to
under-reporting that have been identified in this study.
Introduction
Adverse drug reactions (ADRs) are a public health problem
and have a significant clinical impact related to morbidity
and mortality, resulting in an increased use of health ser-
vices in developed countries [1, 2]. ADRs, many of which
are preventable, are responsible for &6.5% of all hospital
admissions [2, 3], with&2–3% of patients admitted with an
ADR dying as a result of the ADR [2, 4]. Furthermore,
ADRs may occur in 6–20% of patients admitted to hospi-
tals, which increases the hospitalization period and, thereby,
healthcare costs [5]. The average treatment cost associated
with a single ADR may be up to several thousand euros [2].
This cost would be even greater if other costs are consid-
ered, such as hospitalization length of stay, and patient-
related economic, social, and psychological costs [6].
Because not all ADRs of a product are known when
marketing authorization is granted, pharmacovigilance is
needed to learn more about possible harmful effects of a
drug. Pharmacovigilance plays a vital role in ensuring that
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